Promoters pledge 57.49% of Cohance Lifesciences shares to secure loans
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Smallcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Catalyst Trusteeship, acting as onshore security agent for lenders, disclosed a first-ranking pledge over 219,930,170 equity shares (57.49% of capital) of Cohance Lifesciences. The pledge covers shares held by promoter entities Berhyanda (33.34%) and Jusmiral Holdings (24.15%), securing term loan facilities from Barclays, Deutsche Bank, BNP Paribas, MUFG and Standard Chartered under a June 11 facility agreement. Pledge created June 17, 2026.
Over half of promoter shares are now pledged as loan security; risk of forced selling rises if borrowers default on obligations.